These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12926536)

  • 21. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.
    Chmiel-Perzyńska I; Perzyński A; Olajossy B; Gil-Kulik P; Kocki J; Urbańska EM
    J Diabetes Res; 2019; 2019():4957879. PubMed ID: 31737685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
    Kronsteiner C; Baran H; Kepplinger B
    Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
    Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kynurenate production by cultured human astrocytes.
    Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
    J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proconvulsive effects of the mitochondrial respiratory chain inhibitor--3-nitropropionic acid.
    Haberek G; Tomczyk T; Zuchora B; Wielosz M; Turski WA; Urbanska EM
    Eur J Pharmacol; 2000 Sep; 403(3):229-33. PubMed ID: 10973624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
    Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J
    Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
    Baran H; Cairns N; Lubec B; Lubec G
    Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine enhances brain production of kynurenic acid in vitro.
    Kocki T; Kocki J; Wielosz M; Turski WA; Urbanska EM
    Eur J Pharmacol; 2004 Sep; 498(1-3):325-6. PubMed ID: 15364012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration.
    Rejdak R; Junemann A; Grieb P; Thaler S; Schuettauf F; Chorągiewicz T; Zarnowski T; Turski WA; Zrenner E
    Pharmacol Rep; 2011; 63(6):1324-34. PubMed ID: 22358081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II.
    Battaglia G; Rassoulpour A; Wu HQ; Hodgkins PS; Kiss C; Nicoletti F; Schwarcz R
    J Neurochem; 2000 Nov; 75(5):2051-60. PubMed ID: 11032894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 3-nitropropionic acid on kynurenine aminotransferase in the rat brain.
    Csillik A; Knyihár E; Okuno E; Krisztin-Péva B; Csillik B; Vécsei L
    Exp Neurol; 2002 Sep; 177(1):233-41. PubMed ID: 12429225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Kocki T; Turski WA
    Pharmacol Rep; 2017 Jun; 69(3):536-541. PubMed ID: 28364692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenic acid and kynurenine aminotransferase in heart.
    Baran H; Amann G; Lubec B; Lubec G
    Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental hypothyroidism raises brain kynurenic acid - Novel aspect of thyroid dysfunction.
    Tomczyk T; Urbańska EM
    Eur J Pharmacol; 2020 Sep; 883():173363. PubMed ID: 32663543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.